A comparative analysis of high-throughput platforms for validation of a circulating microRNA signature in diabetic retinopathy

Ryan J. Farr, Andrzej S. Januszewski, Mugdha V. Joglekar, Helena Liang, Annie K. McAulley, Alex W. Hewitt, Helen E. Thomas, Tom Loudovaris, Thomas W. H. Kay, Alicia Jenkins, Anandwardhan A. Hardikar

Research output: Contribution to journalArticlepeer-review

55 Citations (Scopus)

Abstract

MicroRNAs are now increasingly recognized as biomarkers of disease progression. Several quantitative real-time PCR (qPCR) platforms have been developed to determine the relative levels of microRNAs in biological fluids. We systematically compared the detection of cellular and circulating microRNA using a standard 96-well platform, a high-content microfluidics platform and two ultrahigh content platforms. We used extensive analytical tools to compute inter- and intra-run variability and concordance measured using fidelity scoring, coefficient of variation and cluster analysis. We carried out unprejudiced next generation sequencing to identify a microRNA signature for Diabetic Retinopathy (DR) and systematically assessed the validation of this signature on clinical samples using each of the above four qPCR platforms. The results indicate that sensitivity to measure low copy number microRNAs is inversely related to qPCR reaction volume and that the choice of platform for microRNA biomarker validation should be made based on the abundance of miRNAs of interest.
Original languageEnglish
Article number10375
Number of pages11
JournalScientific Reports
Volume5
DOIs
Publication statusPublished - 2015

Open Access - Access Right Statement

This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Fingerprint

Dive into the research topics of 'A comparative analysis of high-throughput platforms for validation of a circulating microRNA signature in diabetic retinopathy'. Together they form a unique fingerprint.

Cite this